رجوع
نطاق اليوم
KWD 237.41
KWD 243.98
نطاق 52 أسبوعًا
KWD 187.43
KWD 322.34
حجم التداول
590,623
متوسط 50 يوم / 200 يوم
KWD 246.84
/
KWD 252.44
الإغلاق السابق
KWD 237.03
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 35.2 | 0.4 |
| P/B | 5.5 | 2.9 |
| ROE % | 16.9 | 3.7 |
| Net Margin % | 16.1 | 3.8 |
| Rev Growth 5Y % | 2.1 | 10.0 |
| D/E | 0.1 | 0.2 |
النقاط الرئيسية
Revenue grew 2.08% annually over 5 years — modest growth
ROE of 16.85% — decent returns on equity
Net margin of 16.06% shows strong profitability
Debt/Equity of 0.13 — conservative balance sheet
Generating 468.90M in free cash flow
P/E of 35.22 — premium valuation
النمو
Revenue Growth (5Y)
2.08%
Revenue (1Y)6.26%
Earnings (1Y)0.20%
FCF Growth (3Y)6.36%
الجودة
Return on Equity
16.85%
ROIC12.89%
Net Margin16.06%
Op. Margin20.09%
الأمان
Debt / Equity
0.13
Current Ratio3.02
Interest Coverage1029.00
التقييم
P/E Ratio
35.22
P/B Ratio5.47
EV/EBITDA27.55
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6.26% | Revenue Growth (3Y) | 2.06% |
| Earnings Growth (1Y) | 0.20% | Earnings Growth (3Y) | -8.79% |
| Revenue Growth (5Y) | 2.08% | Earnings Growth (5Y) | -7.06% |
| Profitability | |||
| Revenue (TTM) | 3.07B | Net Income (TTM) | 493.70M |
| ROE | 16.85% | ROA | 11.56% |
| Gross Margin | 35.89% | Operating Margin | 20.09% |
| Net Margin | 16.06% | Free Cash Flow (TTM) | 468.90M |
| ROIC | 12.89% | FCF Growth (3Y) | 6.36% |
| Safety | |||
| Debt / Equity | 0.13 | Current Ratio | 3.02 |
| Interest Coverage | 1029.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 35.22 | P/B Ratio | 5.47 |
| P/S Ratio | 5.66 | PEG Ratio | 34.00 |
| EV/EBITDA | 27.55 | Dividend Yield | 0.00% |
| Market Cap | 17.39B | Enterprise Value | 17.01B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.07B | 2.89B | 2.95B | 2.89B | 2.83B |
| Net Income | 493.70M | 492.70M | 593.40M | 585.90M | 661.80M |
| EPS (Diluted) | 6.80 | 6.69 | 7.88 | 7.73 | 8.67 |
| Gross Profit | 1.10B | 1.00B | 1.13B | 1.14B | 1.17B |
| Operating Income | 617.40M | 594.60M | 710.90M | 763.50M | 758.70M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 4.27B | 3.64B | 3.83B | 3.62B | 3.31B |
| Total Liabilities | 1.09B | 961.10M | 948.50M | 931.90M | 978.40M |
| Shareholders' Equity | 3.18B | 2.68B | 2.88B | 2.68B | 2.34B |
| Total Debt | 416.70M | 305.30M | 309.00M | 317.90M | 325.30M |
| Cash & Equivalents | 791.30M | 484.60M | 853.90M | 894.30M | 762.60M |
| Current Assets | 1.98B | 1.54B | 1.94B | 1.92B | 1.74B |
| Current Liabilities | 654.90M | 550.40M | 671.80M | 519.00M | 594.10M |